Fig. 2From: Prognostic risk assessment model and drug sensitivity analysis of colon adenocarcinoma (COAD) based on immune-related lncRNA pairsDifferences in the high-risk group and the low-risk group. A Prognostic risk score distribution diagram of colon cancer patients. B Distribution of patients' survival status and survival time. C The training set. Kaplan–Meier survival curve of colon cancer patients from the low-risk group and the high-risk group. The high-risk group showed a poorer prognosis. D The validation setBack to article page